CA-DISTRIBUTED-BIO
Distributed Bio , a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce a multi target research collaboration with John DiPersio, MD, PhD, Chief of the Division of Oncology at Washington University School of Medicine and Deputy Director of the Alvin J. Siteman Cancer Center in St. Louis. Distributed Bio will use its proprietary SuperHuman antibody discovery and engineering platform to discover and optimize therapeutics in collaboration with Dr. DiPersio.
“We are delighted to collaborate with Dr. DiPersio on antibody discovery,” says Jacob Glanville, Co-Founder and Chief Executive Officer of Distributed Bio. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design. From analyzing thousands of human immune systems with our machine learning AbGenesis platform, we have harvested from nature the rules of making exceptional therapeutic repertoires. The result is a library of 76 billion antibodies that contains over 5,000 hits against any antigen, thermostable, non-immunogenic, pre-screened by human blood and therapeutically developed in advance to avoid engineering delays downstream. This is an order of magnitude more molecules than can be generated by other technologies, and enables our partners to search for ultra-specific, species-cross reactive therapeutic antibodies at unprecedented speeds. The libraries overcome many of the limitations of other monoclonal generation technologies that have resulted in a unique engineering opportunity: a library that can generate unique and developable hits against every antigen tested, enabling routine success against targets that used to be nearly insurmountable – GPCRs, Ion Channels, pMHC complexes, broadly-neutralizing antibodies against HIV, therapeutic anti-idiotypic antibodies, bi-epitopic antibodies, and mouse/NHP/human cross-reactive antibodies.”
Under the terms of the collaboration, Distributed Bio will use its SuperHuman antibody library to discover novel therapeutic antibodies to targets selected by Dr. DiPersio and will also use its Tumbler technology to optimize clones that he already has identified. The lead clones will then be further developed by Dr. DiPersio.
About Distributed Bio
Distributed Bio is a computational immunoengineering biotechnology group, self-funded by the success of the stack of antibody discovery, optimization and analysis technologies to partners across the pharmaceutical industry. Our mission is to disrupt biologic engineering with big data, machine learning, and computational immunology-driven design.
From a team that includes inventors of antibody repertoire sequencing technologies, their AbGenesis antibody and TCR repertoire analysis and engineering platform enables partners to analyze antibody repertoires by high-throughput sequence, Sanger sequence, and functional assay without requiring large data center investments or local bioinformatics specialists. By using AbGenesis to analyze thousands of antibody repertoires and antibody libraries, they developed the computationally optimized SuperHuman 2.0 antibody library, the SLiC single light chain library, the Tungsten humanized VHH library, CAR-T discovery library, and the Cosmic antibody library.
In 2018, Distributed Bio entered into an exclusive partnership with Charles River, a leading provider of essential products and services for pharmaceutical and biotechnology companies, government agencies and leading academic institutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005196/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Paysafe Research: First-Time and Casual Betting to Surge for 2026 World Cup14.1.2026 15:10:00 CET | Press release
60% of World Cup fans plan to bet online, marking a major revenue opportunity for online sportsbooks with optimized payments tailored to local preferences 19% of global consumers with an interest in following this summer’s 2026 World Cup plan to place their first ever online bet during the soccer tournament, according to research issued today by leading payments platform Paysafe (NYSE: PSFE). The company’s All the Ways Players Pay: World Cup 2026 report also indicates that brand reputation and offering flexible, reliable payments will be crucial for online sportsbooks when converting and retaining new and experienced bettors alike. With the World Cup returning to North America for the first time since 1994, there is strong appetite for online wagering in the host countries of the U.S., Mexico, and Canada as well as in Europe and Latin America, with 60% of global fans planning to bet. Across U.S. states where sports betting is legal, 62% intend to wager, with 29% placing their first eve
New Experian Study Reveals Critical Role of AI in Lending and Key Drivers of Accelerated Adoption by Financial Institutions14.1.2026 15:00:00 CET | Press release
Increasing interest driven by efficiency and risk-mitigation gains, balanced by caution around compliance, data quality and integration A recent Experian Perceptions of AI Report that polled more than 200 decision-makers at leading financial institutions on their AI investment strategy offers key insights into their adoption of AI and expected outcomes when investing in the technology. Notably, AI adoption among financial institutions is accelerating, with 84% of respondents identifying AI technology as being critical or a high priority for their business strategy over the next two years. Further underscoring AI’s strategic importance, a striking 89% state that it will play a critical role across the lending lifecycle. Study findings shed light on that role, pointing to several essential outcomes that respondents expect when investing in AI, including increased operational efficiency, improved credit decisioning accuracy and more effective risk mitigation. “This study helps us better u
Joint Cross-industry Statement: Cement Industry Co-Processing Should Be More Widely Adopted for Global Sustainable Waste Management14.1.2026 15:00:00 CET | Press release
Leading industry organisations today issued a joint statement highlighting the substantial and positive contribution the cement industry can make to addressing the urgent global challenge of non-recyclable and non-reusable waste. The Global Cement and Concrete Association – GCCA; European Composites Industry Association (EuCIA); International Solid Waste Association – Africa; Mission Possible Partnership; and The Global Waste-to-Energy Research and Technology Council – WtERT® are calling for stronger policy support to unlock the full potential of cement industry co-processing as a safe, effective and sustainable global waste management solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114232332/en/ Co-processing enables both energy recovery and material recycling. It uses waste to replace fossil fuels in heating cement kilns, while any remaining ashes are simultaneously recycled into the building material compound
Prometheus Announces Breakthrough e-Kerosene Pathway to Make Cost-Competitive SAF and Diesel from Electricity and Air14.1.2026 14:57:00 CET | Press release
Company reveals world’s first 100% electrochemical pathway for producing e-kerosene directly from atmospheric CO2 and renewable electricity without hydrogen, making Fischer-Tropsch obsolete. Prometheus Fuels today announced its revolutionary new pathway for producing synthetic paraffinic kerosene (the basis for SAF jet fuel and e-diesel) from direct air capture of CO2 and off-grid renewable electricity. The new Prometheus e-kerosene pathway makes Fischer-Tropsch synthesis obsolete, reducing the cost to make e-fuels by more than 80 percent compared to the century-old technology. It is also the first process in history to make kerosene from electricity and atmospheric CO2 without using hydrogen. The kerosene produced is 100 percent carbon neutral. Two independent engineering reviews confirmed demonstration of the new pathway using commercial-scale cells. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114310118/en/ Because t
Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream14.1.2026 14:00:00 CET | Press release
Rapyd’s 2026 State of Stablecoins Report shows 64% of businesses surveyed already use stablecoins or plan to within three years, with speed, easier cross-border transactions, and cost savings driving adoption Rapyd, a leading global fintech company, released its 2026 State of Stablecoins Report, revealing that stablecoins have reached a tipping point and are becoming a foundational component of global commerce rather than a niche digital asset. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114427729/en/ Rapyd research shows 64% of businesses already use stablecoins or plan to within three years, as speed, cross-border efficiency, and cost savings drive mainstream adoption. The report shows the market has moved decisively into active, real-world use. Today, nearly one in five businesses already consider stablecoins a mainstream financial tool. Looking ahead, a much larger majority (76%) believe stablecoins are either alre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom